The firm is examining the $14.25 per share cash sale of Utz Brands to Intersnack Group and the $31.00 per share acquisition of Caesars Entertainment by Fertitta Entertainment. Parallel investigations target the merger between Victory Capital Holdings and First Eagle Investments, as well as the deal between Fulcrum Therapeutics and Slate Medicines, which would leave existing Fulcrum investors with a 5.0% stake in the combined entity.

Attorneys Daniel Sadeh and Zachary Halper contend that these proposed transactions may include deal protections that unfairly limit superior competing offers. The firm is evaluating whether insiders are receiving preferential financial benefits not extended to the broader investor base. Should the investigations proceed to litigation, the firm intends to seek increased compensation or additional disclosures for shareholders, operating on a contingent fee basis.